Show simple item record

dc.contributor.authorSmith, Megan
dc.contributor.authorAdams, Danielle
dc.contributor.authorCarr, Claudia
dc.contributor.authorMengoni, Silvana
dc.date.accessioned2019-08-07T00:25:22Z
dc.date.available2019-08-07T00:25:22Z
dc.date.issued2019-11-01
dc.identifier.citationSmith , M , Adams , D , Carr , C & Mengoni , S 2019 , ' Do people with intellectual disabilities understand their prescription medication? A scoping review ' , Journal of Applied Research in Intellectual Disabilities , vol. 32 , no. 6 , pp. 1375-1388 . https://doi.org/10.1111/jar.12643
dc.identifier.issn1360-2322
dc.identifier.otherPURE: 15817481
dc.identifier.otherPURE UUID: b5a6234d-bb40-4eef-9f0b-e506497dc536
dc.identifier.otherScopus: 85069857394
dc.identifier.otherORCID: /0000-0001-7449-4531/work/62748513
dc.identifier.otherORCID: /0000-0002-1482-2350/work/62751090
dc.identifier.otherPubMed: 31338972
dc.identifier.urihttp://hdl.handle.net/2299/21544
dc.description© 2019 The Authors. Journal of Applied Research in Intellectual Disabilities Published by John Wiley & Sons Ltd.
dc.description.abstractBackground: People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects. Method: A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved. Results: Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities. Conclusion: There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.en
dc.format.extent14
dc.language.isoeng
dc.relation.ispartofJournal of Applied Research in Intellectual Disabilities
dc.rightsOpen
dc.subjectdecision making
dc.subjectintellectual disability
dc.subjectmedicine
dc.subjectprescriptions
dc.subjectEducation
dc.subjectDevelopmental and Educational Psychology
dc.titleDo people with intellectual disabilities understand their prescription medication? A scoping reviewen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionDepartment of Psychology and Sports Sciences
dc.contributor.institutionLaw
dc.contributor.institutionHertfordshire Law School
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionHealth Research Methods Unit
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85069857394&partnerID=8YFLogxK
dc.relation.schoolSchool of Life and Medical Sciences
dc.relation.schoolHertfordshire Law School
dc.description.versiontypeFinal Published version
dcterms.dateAccepted2019-11-01
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1111/jar.12643
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.rights.accesstypeOpen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record